Walleye Capital
VOR icon

Walleye Capital’s Vor Biopharma VOR Stock Holding History

Walleye Capital’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$858K Buy
+46,612
New +$705K ﹤0.01% 2258
2024
Q2 		– Sell
-828
Closed -$39.2K – 6048
2024
Q1 		$39.2K Buy
+828
New +$36.4K ﹤0.01% 4755
2023
Q2 		– Sell
-823
Closed -$88.6K – 4923
2023
Q1 		$88.6K Sell
823
-7,346
-90% -$814K ﹤0.01% 2997
2022
Q4 		$1.09M Buy
+8,169
New +$808K 0.02% 955

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Walleye Capital's VOR Position: Q2 2026 in Review

Walleye Capital opened a new position in Vor Biopharma (VOR) in Q2 2026: 46,612 shares worth $858K. The stake represents ﹤0.01% of the portfolio and ranks #2258 among its holdings. This is a return to the name: Walleye Capital previously reported a position in VOR as recently as Q1 2024.

Walleye Capital first reported a position in VOR in Q4 2022 and has held it in 4 quarters since. The position peaked at $1.09M in Q4 2022. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Walleye Capital held 46,612 shares of Vor Biopharma worth $858K as of Q2 2026.
  • Vor Biopharma was a new Walleye Capital position in Q2 2026.
  • Vor Biopharma made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2258 holding.
  • Walleye Capital first reported a position in Vor Biopharma in Q4 2022 and has held it in 4 quarters since.
  • Walleye Capital's Vor Biopharma position peaked at $1.09M in Q4 2022.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.